Posted
Article written by
/2021/12/14/61b8b9accb57c_france-3.png)
Unprecedented success has occurred in the treatment of rectal cancer. All of the patients in a clinical trial carried out in a hospital in New York, in the United States, are in remission thanks to immunotherapy. The results are unexpected.
A hospital in New York (United States) conducted a clinical trial on 12 patients with a specific form of rectal cancer, known as “MSI”. The results are spectacular. “We have never seen such a series of memory results in the history of oncology. All patients who received the treatment were cured, i.e. the tumor completely disappeared“, rejoices Dr. Andrea Cercekoncologist.
The treatment in question is immunotherapy. When we have a tumour, it prevents our lymphocytes from working. They are the ones that are normally responsible for attacking cancer cells. “The immunotherapies that are given to patients today are effective because, by striking against these molecules that put the lymphocytes to sleep, they prevent their action and they awaken the patient’s immunity against his tumor.explains Alex Duval, director of the MSI Cancers laboratory at the Saint-Antoine hospital in Paris.
team of the week
-
Editor-in-chief
Pierre-Yves Grenu
-
Deputy editor-in-chief
Valerie Houart, Eric Brisson
-
Editor
–
-
Joker
–
The weekend team
-
Editor-in-chief
Catherine Raymond
-
Deputy editor-in-chief
Jerome Dorville, Daniel Ielli
-
Editor
–
-
Joker
–
view all magazines
all the news in video
Receive the essentials of our news with our newsletter
Newsletter subscription
France Télévisions uses your email address to send you newsletters.
articles on the same topic
Seen from Europe
Franceinfo selects daily content from European public audiovisual media, members of Eurovision. These contents are published in English or French.